Cooperative epigenetic modulation by cancer amplicon genes - Test2 - elhamkhani - TriplyDB

Cooperative epigenetic modulation by cancer amplicon genes

Cooperative epigenetic modulation by cancer amplicon genes

http://www.wikidata.org/entity/Q24608701

about

DNA Methylation and Chromatin Remodeling: The Blueprint of Cancer Epigenetics Integration of Signaling Pathways with the Epigenetic Machinery in the Maintenance of Stem Cells KDM4/JMJD2 histone demethylases: epigenetic regulators in cancer cells JAK2 and genomic instability in the myeloproliferative neoplasms: a case of the chicken or the egg?Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers KDM4C, a H3K9me3 Histone Demethylase, is Involved in the Maintenance of Human ESCC-Initiating Cells by Epigenetically Enhancing SOX2 Expression KDM4C and ATF4 Cooperate in Transcriptional Control of Amino Acid Metabolism Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia.KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage.Pro-growth role of the JMJD2C histone demethylase in HCT-116 colon cancer cells and identification of curcuminoids as JMJD2 inhibitors.Pathobiology of hodgkin lymphoma.A polymorphism in JMJD2C alters the cleavage by caspase-3 and the prognosis of human breast cancer.Identification of novel candidate oncogenes in chromosome region 17p11.2-p12 in human osteosarcoma.Identification and functional analysis of 9p24 amplified genes in human breast cancer.Analysis of the coding genome of diffuse large B-cell lymphoma Systems biology: confronting the complexity of cancer.FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer.Small-molecular modulators of cancer-associated epigenetic mechanisms.MutComFocal: an integrative approach to identifying recurrent and focal genomic alterations in tumor samples.Hodgkin lymphoma.Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib.Primary mediastinal B-cell lymphoma and mediastinal gray zone lymphoma: do they require a unique therapeutic approach?A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma.Emerging therapeutic paradigms to target the dysregulated Janus kinase/signal transducer and activator of transcription pathway in hematological malignancies Histone modifiers in cancer: friends or foes?Targeting protein lysine methylation and demethylation in cancers.SEPTIN2 and STATHMIN Regulate CD99-Mediated Cellular Differentiation in Hodgkin's Lymphoma.The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma.Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition Targeting the interleukin-6/Jak/stat pathway in human malignancies Advances in sarcoma genomics and new therapeutic targets.Negative regulation of JAK2 by H3K9 methyltransferase G9a in leukemia.The histological and biological spectrum of diffuse large B-cell lymphoma in the World Health Organization classification JAK Kinases in Health and Disease: An Update Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression.Integrated genomic and functional analyses of histone demethylases identify oncogenic KDM2A isoform in breast cancer.

P2860

Q26749421-08C0B72D-B501-4D52-B75D-166B52D325A7 Q26769986-EA28ED1F-0BEE-4BE0-891C-4E11A40B958D Q27007679-40B0FFCA-DBF0-4EF9-9FA8-3C3F44CA77C8 Q27012572-0568C42F-34CF-4128-A38E-26B191929801 Q27304386-4AC4798A-CA3A-43F2-8324-5E768DF665CA Q28258198-69A6C673-435F-4FA6-8176-A4A425A19E52 Q28829171-02B0F0BE-5A15-499C-847D-12FBD0FCE5C1 Q29042334-42DCCC2A-FA77-42FE-B9BA-92E2B7CC98D7 Q33292152-4871D724-8659-4251-B5F0-41D9B344074E Q33580494-E2DD6BDB-CBED-42FC-A47B-1F9B79BAB230 Q33757981-D0E7968E-BDD6-4573-93AC-A84AEE10B03E Q33778402-D53746B1-AEC3-4A3E-A1EB-1702F722E4CA Q34104029-697FF54C-2716-47BE-8625-F16B8E1BCB9C Q34146537-6EA7FB19-9CAB-44A2-9211-91FFFC122AA5 Q34191958-95205632-B7F5-4CF7-B92D-D62BF2DEA72A Q34205133-0D538BE5-17E0-4EC9-988F-ED4B0941B1CF Q34213946-995F7602-75FE-406D-994E-9B9E52E770F9 Q34221760-EF7F78E3-457A-49B6-A46D-01801ABA744F Q34322749-CC1B95C9-D6AE-48D0-86E6-6FAE22071222 Q34408939-656700D0-B3EB-4F8E-BF55-0FF219D5E55B Q34475807-DB9DBE5F-FE52-4EA7-8BDE-EF3791FE768D Q34628002-C0B7C5DD-CFF3-492A-A893-342176E996A1 Q34636963-F6125167-B2EB-46C9-832A-1D266498EACD Q34643277-F3448722-ACDA-4224-8F6C-0DBB25190C56 Q34648812-9F4E499D-936F-4B85-B7F8-CFEC9CF1086A Q34802443-0E396308-26CE-4977-A0F4-9095E698C932 Q35084573-4BDD3059-E467-4BC9-BC51-563ED644A162 Q35132241-1244DB82-C72C-43FA-A069-2E9DC6C40331 Q35216079-FEFC8C3B-0691-4AE5-823D-BFFEEDD5C135 Q35629831-AEFFB47A-7B8A-42EE-A3AB-BB5B93C09D91 Q35639424-ED8BCE29-CE2A-4996-9051-C0E053BA394B Q35664956-17A95B66-9774-4567-B602-19CD17ACCB83 Q35760845-E31CF66F-2F2A-448A-A8E3-B3A6D7DE2EA7 Q35925127-859856A1-9FBF-44A4-917B-B2BFE39877C0 Q35993346-46C7DB99-B800-452E-B5C9-8527985FCD45 Q36197079-96D8A227-526B-48E8-94C9-1E510C28D0F8 Q36280547-74863577-0638-4CB2-931C-AC067C25EBBF Q36285745-F78ABD2D-EA14-40AA-A324-3F5553424CFD Q36471184-B881147A-F3C9-427D-A8BA-F1490DD4E25D Q36495170-E45514FE-1B1E-46AF-AB1C-165696A83885

P2860

Cooperative epigenetic modulation by cancer amplicon genes

http://www.wikidata.org/entity/Q24608701

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cooperative epigenetic modulation by cancer amplicon genes

@ast

Cooperative epigenetic modulation by cancer amplicon genes

@en

Cooperative epigenetic modulation by cancer amplicon genes

@nl

type

label

Cooperative epigenetic modulation by cancer amplicon genes

@ast

Cooperative epigenetic modulation by cancer amplicon genes

@en

Cooperative epigenetic modulation by cancer amplicon genes

@nl

prefLabel

Cooperative epigenetic modulation by cancer amplicon genes

@ast

Cooperative epigenetic modulation by cancer amplicon genes

@en

Cooperative epigenetic modulation by cancer amplicon genes

@nl

P1433

Q24608701-57EEE54E-A852-48DA-B257-A1B4172BA1FC

P1476

Q24608701-8E56864F-5E54-4B09-A89C-F64DD8C406AD

P2093

Q24608701-00FA3706-A31F-4BCB-A5FB-3E79AB267CCF

Q24608701-066D4046-B068-4138-BA9E-6709E56D07C5

Q24608701-15FE51C7-4E82-4718-BE1A-10FAF4674CDD

Q24608701-2A5E3C3C-5733-490A-89DC-5AB03E44B805

Q24608701-2E827CBD-92F2-4E17-913C-9863FD7FAB08

Q24608701-2E8BCD01-77FB-49DE-B0D6-FF9B7F6A7E79

Q24608701-4EF6B633-5206-4E84-9B9E-E390ACD928D6

Q24608701-6A0FDBE6-FC19-41E4-898F-BE2395CED24D

Q24608701-8EE9EF96-70AF-4ECC-AEC4-E28862F04260

Q24608701-92B4C5DE-4CCC-4B32-A605-9C0C1C1E68BD

P2860

Q24608701-04733E3F-64B8-4323-A760-67E2052348DE

Q24608701-0FC979D6-D94B-4F82-BD3C-AD55103853C8

Q24608701-1240A865-FE59-408D-984A-051EC5A3B3DE

Q24608701-13417D67-9E66-4B6F-893C-02ABBA2B23EC

Q24608701-14E30722-9E50-4C51-8BB7-5C5450CB8662

Q24608701-16ECAC11-4AAD-42EB-8A20-1D0DC950FFC1

Q24608701-195EF11C-5B9B-4DCE-8B05-C3FE3443E880

Q24608701-27DA8A29-D5C0-4D78-BD5E-EDE22D7343EB

Q24608701-297A12D6-5391-47BC-B9BD-3B14BDC01209

Q24608701-2C2A03F9-BC22-4999-9955-A69CBD1318A7

P304

Q24608701-9882D271-AB57-44B5-9F06-191AC35AD3AB

P31

Q24608701-32F3A011-6CD5-4D00-878B-B765D044F2B9

P3181

Q24608701-768F5E65-9512-4A4D-B25A-6D17013EA30E

P356

Q24608701-46A52764-4403-47E6-B059-094F4AF8A4F6

P407

Q24608701-195F6A2E-EEAC-4FDF-BB68-FA794682A3AE

P433

Q24608701-69B43858-B756-4C55-9E24-9362BCE358FA

P478

Q24608701-26D079AF-6C99-4434-A2D2-0CF4061BC26A

P50

Q24608701-2928E11C-4D04-4F1A-A4F5-A081DE8E4E52

Q24608701-2E73EA19-B532-4A7E-A3F0-52122177145A

Q24608701-5D1ADD3E-7211-4726-AE28-936350C41FAD

Q24608701-63086F0C-5B93-44CD-BFA1-FD14A700CB6E

Q24608701-6C5916AC-4E68-499C-9DBE-2B7C9AAC7107

Q24608701-7735B42A-5519-4D76-8732-DD9649783BF7

Q24608701-79F3CC74-73C9-43B4-89B9-4740E95499D6

Q24608701-B156EC15-C885-4341-ABB7-CEBD9CD906A2

Q24608701-C0C66317-DAE5-4A67-9503-944556349C87

Q24608701-C96BA4C9-6DFA-4DE2-B2FB-91751A77AAB3

P577

Q24608701-CF77CCC9-6B05-4935-B2FF-06CE5A7F9B4B

P5875

Q24608701-ED1B0CAE-AE16-40C9-83A4-9F49EF0ED264

P698

Q24608701-AD5052D4-35BA-4756-BC96-2A5461517E9F

P921

Q24608701-102FC750-E4B7-4242-8827-CAB2764158B8

P932

Q24608701-5AEE4B89-29E0-4F54-B694-F52EBCF137A7

P3181

P356

J.CCR.2010.11.013

P1433

P1476

Cooperative epigenetic modulation by cancer amplicon genes

@en

P2093

Arthur L Shaffer

http://www.w3.org/2001/XMLSchema#string

Christian Steidl

http://www.w3.org/2001/XMLSchema#string

Craig J Thomas

http://www.w3.org/2001/XMLSchema#string

David Levens

http://www.w3.org/2001/XMLSchema#string

Georg Lenz

http://www.w3.org/2001/XMLSchema#string

George W Wright

http://www.w3.org/2001/XMLSchema#string

Graham Slack

http://www.w3.org/2001/XMLSchema#string

Hong Zhao

http://www.w3.org/2001/XMLSchema#string

Hye-Jung Chung

http://www.w3.org/2001/XMLSchema#string

John Powell

http://www.w3.org/2001/XMLSchema#string

P2860

Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression

Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system

Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases

JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin

Janus kinases in immune cell signaling

In vivo HP1 targeting causes large-scale chromatin condensation and enhanced histone lysine methylation

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

Global mapping of c-Myc binding sites and target gene networks in human B cells

Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.

P304

590-605

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2694588

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CCR.2010.11.013

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Erlend B. Smeland

Hans Konrad Müller-Hermelink

David G. Maloney

Andreas Rosenwald

Joseph M Connors

P577

2010-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49681683

http://www.w3.org/2001/XMLSchema#string

P698

21156283

http://www.w3.org/2001/XMLSchema#string

P921

P932

3049192

http://www.w3.org/2001/XMLSchema#string